Download Files:
Products Details
Product Description
– Xalnesiran is siRNA for the treatment of chronic hepatitis B (HBV).
Web ID
– HY-145638
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C664H871F17N231O415P57S6
References
– [1]WHO Drug Information, Vol. 35, No. 4, 2021
CAS Number
– 2538784-48-2
Molecular Weight
– 21009.15
SMILES
– [Xalnesiran]
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in H2O
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
